` POLYMED (Poly Medicure Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

POLYMED
vs
BSE Sensex 30

Over the past 12 months, POLYMED has significantly outperformed BSE Sensex 30, delivering a return of 89% compared to the BSE Sensex 30's 9% growth.

Stocks Performance
POLYMED vs BSE Sensex 30

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
POLYMED vs BSE Sensex 30

Loading
POLYMED
BSE Sensex 30
Difference

Performance By Year
POLYMED vs BSE Sensex 30

Loading
POLYMED
BSE Sensex 30
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Poly Medicure Ltd vs Peers

BSE Sensex 30
POLYMED
7741
ALC
COLO B
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Poly Medicure Ltd
Glance View

Market Cap
289B INR
Industry
Health Care

Poly Medicure Ltd., an Indian manufacturer of medical devices, is a compelling narrative of innovation driving tangible impact in healthcare. It embarked on its journey in the late 1990s, seizing on the escalating demand for high-quality medical consumables. The company carved its niche by producing a wide array of disposable medical devices like catheters, infusion therapy systems, and wound closure products, essential in medical facilities worldwide. By establishing a robust manufacturing infrastructure and leveraging economies of scale, Poly Medicure ensures competitive pricing while adhering to global quality standards. A dedication to research and development undergirds their operation, constantly pushing the envelope of modern medical technology. Revenue streams flow primarily from the sale of these innovative products to hospitals, healthcare institutions, and distributors across more than 100 countries. The company's strategic positioning in the industry is further reinforced by its commitment to sustainability and stringent adherence to regulatory compliance, which helps in sustaining long-term contracts and partnerships. The expansion of its product range and the adoption of automated manufacturing processes don't just meet but often forecast sector demands. By keeping its pulse on global health trends, Poly Medicure ensures not only stable growth in its financial graphs but also cements its authority as a cornerstone entity in the medical supplies marketplace.

POLYMED Intrinsic Value
1 334.1583 INR
Overvaluation 53%
Intrinsic Value
Price
Back to Top